Moreover, Toraih et al. demonstrated that circulatory MALAT1 might act as the putative non-invasive prognostic and diagnostic biomarker showing a worse liver failure score in HCV- related HCC patients with traditional markers [64]. Here, MALAT1 is linked to hepatocellular carcinoma.